Proficio Capital Partners LLC Vericel Corp Transaction History

Proficio Capital Partners LLC

  • $969 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 19, 2023
BUY
$23.85 - $31.34 $241,242 - $317,004
10,115 New
10,115 $296,000
Q3 2019

Nov 13, 2019
SELL
$14.93 - $19.83 $641 - $852
-43 Closed
0 $0
Q2 2019

Aug 13, 2019
SELL
$15.01 - $18.89 $690 - $868
-46 Reduced 51.69%
43 $1,000
Q1 2019

May 13, 2019
BUY
$16.23 - $20.29 $1,444 - $1,805
89 New
89 $2,000

Others Institutions Holding VCEL

# of Institutions
279
Shares Held
48.7M
Call Options Held
91.8K
Put Options Held
23.2K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.76B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Proficio Capital Partners LLC Portfolio

Follow Proficio Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email